These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 24071015

  • 1. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li T, Zhang B.
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [Abstract] [Full Text] [Related]

  • 2. Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.
    Li W, Wang Y, Fang X, Zhou M, Li Y, Dong Y, Wang R.
    Med Sci Monit; 2017 Feb 21; 23():938-947. PubMed ID: 28220037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
    Wang Y, Adila S, Zhang X, Dong Y, Li W, Zhou M, Li T.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 21; 43(2):88-94. PubMed ID: 24742567
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
    Yoneyama K, Ishibashi O, Kawase R, Kurose K, Takeshita T.
    Anticancer Res; 2015 Mar 21; 35(3):1401-10. PubMed ID: 25750291
    [Abstract] [Full Text] [Related]

  • 9. [Characteristic and clinical significance of DNA methyltransferase 3B overexpression in endometrial carcinoma].
    Dong Y, Zhou M, Ba XJ, Si JW, Li WT, Wang Y, Li D, Li T.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct 18; 48(5):788-794. PubMed ID: 27752157
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.
    Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A.
    Gynecol Oncol; 2014 Jul 18; 134(1):20-3. PubMed ID: 24814467
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
    Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW.
    Gynecol Oncol; 2005 Feb 18; 96(2):531-8. PubMed ID: 15661247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D, Wang X, Zhang Y, Zhao J, Han R, Dong Y.
    Chin Med J (Engl); 2019 Jan 20; 132(2):161-170. PubMed ID: 30614867
    [Abstract] [Full Text] [Related]

  • 14. PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.
    Dong Y, Yang X, Wong O, Zhang X, Liang Y, Zhang Y, Wong W, Nong L, Liao Q, Li T.
    Hum Pathol; 2012 Aug 20; 43(8):1197-205. PubMed ID: 22209294
    [Abstract] [Full Text] [Related]

  • 15. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R, Bogusiewicz M, Tarkowski R, Ciotta C, Bignami M, Burnouf D, Jakowicki JA.
    Oncol Rep; 2003 Aug 20; 10(4):1039-43. PubMed ID: 12792767
    [Abstract] [Full Text] [Related]

  • 16. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G, Peiró FM, Ortiz-Martínez F, Planelles M, Sánchez-Tejada L, Alenda C, Ceballos S, Sánchez-Payá J, Laforga JB.
    Hum Pathol; 2013 Feb 20; 44(2):218-25. PubMed ID: 22955108
    [Abstract] [Full Text] [Related]

  • 17. Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas.
    de Jong RA, Boerma A, Boezen HM, Mourits MJ, Hollema H, Nijman HW.
    Int J Cancer; 2012 Oct 15; 131(8):1828-36. PubMed ID: 22287095
    [Abstract] [Full Text] [Related]

  • 18. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I, Tozlu S, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Oct 01; 9(12):4415-22. PubMed ID: 14555514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.